 |
 |
 |
|
The Impact of Extracorporeal Removal Techniques
on Outcome of Sepsis
Jonathan Cohen, MD,[10] of Brighton and Sussex Medical
School in Falmer, United Kingdom, discussed the extent
to which extracorporeal removal techniques affect the
outcome of sepsis and reviewed general concepts as well
as the results of clinical trials. These therapies attempt
to counteract the physiologic response to sepsis mediators
by removing those that are toxic or harmful from the
circulation. Therapies can be viewed as nonselective
(eg, hemofiltration, hemoperfusion, plasmapheresis/exchange)
or selective (eg, leukopheresis, endotoxin removal).
General issues to consider include the potential for
a detrimental effect from removal of beneficial factors
in addition to those considered harmful, as well as
safety concerns related to hemodynamic stability and
infection. A recently published prospective, randomized,
controlled trial suggested that decreased mortality
from plasma exchange was possible in severe sepsis and
septic shock.[11] However, differences in baseline demographics
(age) and clinical variables (site of infection, percent
of patients requiring mechanical ventilation) were present.
Correcting for these variables reduced the significance
of treatment with plasmapheresis on mortality; and although
a trend still existed favoring plasma exchange, it was
no longer a statistically significant effect. Clinical
information regarding the role of more selective modalities,
such as the use of endotoxin adsorbers, is limited,[12]
although the experimental techniques to target the removal
of superantigens or potent immunostimulating toxins
represent an area of active investigation. In aggregate,
experimental studies to date are perceived as encouraging,
but clinical data remain fragmentary and incomplete.
|
|
|
|
| 版权所有:好医生网站 |
|